MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy

References

• Pettitt DJ, Talton J, Dabelea D, et al. Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study. Diabetes Care. 2014;37(2):402–408.
   PubMed Web of Science ®Google Scholar
• Faulds ER, Zappe J, Dungan KM. Real-world implications of Hybrid Close Loop (HCL) insulin delivery system. Endocr Pract. 2019;25(5):477–484.
   PubMed Web of Science ®Google Scholar
• Zaccardi F, Webb DR, Yates T, et al. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016;92(1084):63–69.
   PubMed Web of Science ®Google Scholar
• Messer LH, Berget C, Beatson C, et al. Preserving skin integrity with chronic device use in diabetes. Diabetes Technol Ther. 2018;20(S2):S254–s264.
   PubMedGoogle Scholar
• Pala L, Dicembrini I, Mannucci E. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials. Acta Diabetol. 2019;56:973–980.
   PubMed Web of Science ®Google Scholar
• Vettoretti M, Facchinetti A. Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review. Biomed Eng Online. 2019;18(1):37.
   PubMed Web of Science ®Google Scholar
• Allen N, Gupta A. Current diabetes technology: striving for the artificial pancreas. Diagnostics (Basel). 2019;9(1).
   PubMedGoogle Scholar
• Ly TT, Weinzimer SA, Maahs DM, et al. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance. Pediatr Diabetes. 2017;18(5):348–355.
   PubMed Web of Science ®Google Scholar
• Mauseth R, Hirsch IB, Bollyky J, et al. Use of a “fuzzy logic” controller in a closed-loop artificial pancreas. Diabetes Technol Ther. 2013;15(8):628–633.
   PubMed Web of Science ®Google Scholar
• Doyle FJ 3rd, Huyett LM, Lee JB, et al. Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care, 2014. 37(5): 1191–1197.
   PubMed Web of Science ®Google Scholar
• Stone MP, Agrawal P, Chen X, et al. Retrospective analysis of 3-month real-world glucose data after the MiniMed 670G system commercial launch. Diabetes Technol Ther. 2018;20(10):689–692.
   PubMed Web of Science ®Google Scholar
• Garg SK, Weinzimer SA, Tamborlane WV, et al. Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther. 2017;19(3):155–163.
   PubMed Web of Science ®Google Scholar
• Messer LH, Forlenza GP, Sherr JL, et al. Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the MiniMed 670G system. Diabetes Care. 2018;41(4):789–796.
   PubMed Web of Science ®Google Scholar
• Forlenza GP, Pinhas-Hamiel O, Liljenquist DR, et al. Safety evaluation of the MiniMed 670G system in children 7–13 years of age with type 1 diabetes. Diabetes Technol Ther. 2019;21(1):11–19.
   PubMed Web of Science ®Google Scholar
• Forlenza GP, Li Z, Buckingham BA, et al. Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial. Diabetes Care. 2018;41(10):2155–2161.
   PubMed Web of Science ®Google Scholar
• Zhong A, Choudhary P, McMahon C, et al. Effectiveness of automated insulin management features of the MiniMed® 640G sensor-augmented insulin pump. Diabetes Technol Ther. 2016;18(10):657–663.
   PubMed Web of Science ®Google Scholar
• Messer LH, Berget C, Forlenza GP. A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm. Diabetes Technol Ther. 2019;21:462–469.
   Web of Science ®Google Scholar
• Zaharieva DP, Turksoy K, McGaugh SM, et al. Lag time remains with newer real-time continuous glucose monitoring technology during aerobic exercise in adults living with type 1 diabetes. Diabetes Technol Ther. 2019;21(6):313–321.
   PubMed Web of Science ®Google Scholar
• Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018. Diabetes Technol Ther. 2019;21(2):66–72.
   PubMed Web of Science ®Google Scholar
• Beck RW, Miller KM, Foster NC. The T1D exchange clinic network and registry: 10 years of enlightenment on the state of type 1 diabetes in the United States. Diabetes Technol Ther. 2019;21(6):310–312.
   PubMed Web of Science ®Google Scholar
• Rodbard D. State of type 1 diabetes care in the united states in 2016–2018 from T1D exchange registry data. Diabetes Technol Ther. 2019;21(2):62–65.
   PubMed Web of Science ®Google Scholar
• Tanenbaum ML, Hanes SJ, Miller KM, et al. Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets. Diabetes Care. 2017;40(2):181–187.
   PubMed Web of Science ®Google Scholar
• Aleppo G, Webb KM. Integrated insulin pump and continuous glucose monitoring technology in diabetes care today: a perspective of real-life experience with the minimed() 670g hybrid closed-loop system. Endocr Pract. 2018;24(7):684–692.
   PubMed Web of Science ®Google Scholar
• Ruiz JL, Sherr JL, Cengiz E, et al. Effect of insulin feedback on closed-loop glucose control: a crossover study. J Diabetes Sci Technol. 2012;6(5):1123–1130.
   PubMedGoogle Scholar
• Christiansen MP, Garg SK, Brazg R, et al. Accuracy of a fourth-generation subcutaneous continuous glucose sensor. Diabetes Technol Ther. 2017;19(8):446–456.
   PubMed Web of Science ®Google Scholar
• Slover RH, Tryggestad JB, DiMeglio LA, et al. Accuracy of a fourth-generation continuous glucose monitoring system in children and adolescents with type 1 diabetes. Diabetes Technol Ther. 2018;20(9):576–584.
   PubMed Web of Science ®Google Scholar
• Medtronic. Comparing infusion sets. [cited 2019 Jun 11]. Available from: https://www.medtronicdiabetes.com/customer-support/infusion-set-support/compare-set.
   Google Scholar
• Berget C, Thomas SE, Messer LH, et al. A clinical training program for hybrid closed loop therapy in a pediatric diabetes clinic. J Diabetes Sci Technol. 2019;1932296819835183. doi: 10.1177/1932296819835183. PubMed PMID: 30862242.
   Google Scholar
• Steil GM, Rebrin K, Darwin C, et al. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006;55(12):3344–3350.
   PubMed Web of Science ®Google Scholar
• Berget C, Messer LH, Pyle L, et al. Real-World Use of Hybrid Closed-Loop Therapy in Pediatric Patients with Type 1 Diabetes. Diabetes. 2018;67(Supplement 1):977-P. doi: 10.2337/db18-977-P.
   Google Scholar
• Pickup JC, Holloway MF, Samsi K. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives. Diabetes Care. 2015;38(4):544–550.
   PubMed Web of Science ®Google Scholar
• Brown S, Raghinaru D, Emory E, et al. First look at control-IQ: a new-generation automated insulin delivery system. Diabetes Care. 2018;41(12):2634–2636.
   PubMed Web of Science ®Google Scholar
• Ekhlaspour L, Forlenza GP, Chernavvsky D, et al. Closed loop control in adolescents and children during winter sports: use of the tandem control-IQ AP system. Pediatr Diabetes. 2019.
   PubMedGoogle Scholar
• Forlenza GP, Ekhlaspour L, Breton M, et al. Successful at-home use of the tandem control-IQ artificial pancreas system in young children during a randomized controlled trial. Diabetes Technol Ther. 2019;21(4):159–169.
   PubMed Web of Science ®Google Scholar
• Buckingham BA, Forlenza GP, Pinsker JE, et al. Safety and feasibility of the omnipod hybrid closed-loop system in adult, adolescent, and pediatric patients with type 1 diabetes using a personalized model predictive control algorithm. Diabetes Technol Ther. 2018;20(4):257–262.
   PubMed Web of Science ®Google Scholar
• Buckingham BA, Christiansen MP, Forlenza GP, et al. Performance of the omnipod personalized model predictive control algorithm with meal bolus challenges in adults with type 1 diabetes. Diabetes Technol Ther. 2018;20(9):585–595.
   PubMed Web of Science ®Google Scholar
• Forlenza GP, Buckingham BA, Christiansen MP, et al. Performance of omnipod personalized model predictive control algorithm with moderate intensity exercise in adults with type 1 diabetes. Diabetes Technol Ther. 2019;21(5):265–272.
   PubMed Web of Science ®Google Scholar
• Hng TM, Burren D. Appearance of Do-It-Yourself closed-loop systems to manage type 1 diabetes. Intern Med J. 2018;48(11):1400–1404.
   PubMed Web of Science ®Google Scholar
• Marshall DC, Holloway M, Korer M, et al. Do-It-yourself artificial pancreas systems in type 1 diabetes: perspectives of two adult users, a caregiver and three physicians. Diabetes Ther. 2019.
   Web of Science ®Google Scholar
• Messer LH, Forlenza GP, Wadwa RP, et al. The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration. Pediatr Diabetes. 2018;19(1):14–17.
   PubMed Web of Science ®Google Scholar
• Salehi P, Roberts AJ, Kim GJ. Efficacy and safety of real life usage of MiniMed 670G automode in children with type 1 diabetes less than 7 years old. Diabetes Technol Ther. 2019;21:448–451.
   PubMed Web of Science ®Google Scholar
• GlobeNewswire. Medtronic’s MiniMed 670G hybrid closed loop system earns EU approval. 2018 [cited 2019 Jun 21]. Available from: https://www.mpo-mag.com/contents/view_breaking-news/2018-06-25/medtronics-minimed-670g-hybrid-closed-loop-system-earns-eu-approval.
   Google Scholar
• Idlebrook C Medtronic 670G and Tandem t:slim X2 approved in Canada. 2018 [cited 2019 Jun 21]. Available from: https://myglu.org/articles/medtronic-670g-and-tandem-t-slim-x2-approved-in-canada.
   Google Scholar
• Messer LH. Why expectations will determine the future of artificial pancreas. Diabetes Technol Ther. 2018;20(S2):S265–s268.
   PubMedGoogle Scholar
• Lee MH, Vogrin S, Paldus B, et al. Glucose control in adults with type 1 diabetes using a medtronic prototype enhanced-hybrid closed-loop system: a feasibility study. Diabetes Technol Ther. 2019;21(9):499–506.
   PubMed Web of Science ®Google Scholar
• Payne FW, Ledden B, Lamps G. Capabilities of next-generation patch pump: improved precision, instant occlusion detection, and dual-hormone therapy. J Diabetes Sci Technol. 2019;13(1):49–54.
   PubMedGoogle Scholar
• Ramkissoon CM, Herrero P, Bondia J, et al. Unannounced meals in the artificial pancreas: detection using continuous glucose monitoring. Sensors (Basel). 2018;18(3):884.
   PubMed Web of Science ®Google Scholar
• Samadi S, Rashid M, Turksoy K, et al. Automatic detection and estimation of unannounced meals for multivariable artificial pancreas system. Diabetes Technol Ther. 2018;20(3):235–246.
   PubMed Web of Science ®Google Scholar